GIA
BIO icon

Gateway Investment Advisers’s Bio-Rad Laboratories Class A BIO Stock Holding History

Gateway Investment Advisers’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,158
Closed -$380K – 508
2024
Q4 		$380K Buy
1,158
+373
+48% +$127K ﹤0.01% 410
2024
Q3 		$263K Sell
785
-90
-10% -$28.6K ﹤0.01% 466
2024
Q2 		$239K Sell
875
-39
-4% -$11.3K ﹤0.01% 470
2024
Q1 		$316K Sell
914
-21
-2% -$6.91K ﹤0.01% 438
2023
Q4 		$302K Sell
935
-140
-13% -$43.9K ﹤0.01% 436
2023
Q3 		$385K Buy
1,075
+44
+4% +$17K ﹤0.01% 406
2023
Q2 		$391K Buy
1,031
+381
+59% +$155K ﹤0.01% 405
2023
Q1 		$311K Buy
650
+114
+21% +$53.4K ﹤0.01% 436
2022
Q4 		$225K Buy
+536
New +$216K ﹤0.01% 504
2022
Q3 		– Sell
-912
Closed -$451K – 512
2022
Q2 		$451K Buy
912
+307
+51% +$160K 0.01% 433
2022
Q1 		$341K Hold
605
– – ﹤0.01% 476
2021
Q4 		$457K Buy
605
+54
+10% +$40.4K ﹤0.01% 429
2021
Q3 		$411K Buy
551
+63
+13% +$47.2K ﹤0.01% 436
2021
Q2 		$314K Sell
488
-13
-3% -$7.91K ﹤0.01% 476
2021
Q1 		$286K Buy
501
+5
+1% +$2.96K ﹤0.01% 483
2020
Q4 		$289K Sell
496
-21
-4% -$12K ﹤0.01% 477
2020
Q3 		$266K Buy
517
+51
+11% +$25.8K ﹤0.01% 470
2020
Q2 		$210K Buy
+466
New +$206K ﹤0.01% 510

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gateway Investment Advisers's BIO Position: Q1 2025 in Review

Gateway Investment Advisers sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 1,158 shares — an estimated $380K sold.

Gateway Investment Advisers first reported a position in BIO in Q2 2020 and held it in 18 quarters. The position peaked at $457K in Q4 2021. 435 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

  • Gateway Investment Advisers reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
  • Gateway Investment Advisers sold 1,158 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $380K.
  • Gateway Investment Advisers first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 18 quarters.
  • Gateway Investment Advisers's Bio-Rad Laboratories Class A position peaked at $457K in Q4 2021.
  • 435 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Gateway Investment Advisers's 13F filing for Q1 2025, filed 11 Apr 2025.